Abstract/Details

Insertional Mutagenesis as a Tool for Identifying and Characterizing Novel Candidate Cancer Genes


2011 2011

Other formats: Order a copy

Abstract (summary)

Cancer results from dynamic changes in a set of cellular genes. Mutations in oncogenes and tumor suppressor genes are responsible for converting a normal cell into a malignant one. Much research has been done to identify a large number of oncogenes and tumor suppressor genes that are frequently mutated in human cancers. These efforts suggest that the cancer genome is composed of a few commonly mutated genes along with hundreds of infrequently mutated genes. Deciphering which of the mutations are important in tumorigenesis will aid in understanding the biology of cancer as well as provide potential new therapeutic targets.

Mouse models of human cancer have been used to determine the significance genetic alterations identified in human cancers. One tool that has been used for this purpose in the mouse is insertional mutagenesis. In our study, we designed a Sleeping Beauty transposon-based forward genetic screen in mice to identify candidate genes for breast cancer in the presence and absence of Cav1 mutations. Analysis of transposon integrations in all mammary tumors identified 210 common insertion sites (CISs) and candidate (CAN) genes were assigned to many of the CISs. Multiple CAN genes have been previously implicated in human breast cancers. Identifying the roles of these 210 CAN genes in tumorigenesis will determine their significance in human breast cancer.

In this study, we also investigated the role of a transcription factor, Meis1, which was originally identified in murine leukemias caused by retroviral-induced insertional mutagenesis. Overexpression of Meis1 in conjunction with HoxA9 is detected in a variety of myeloid leukemia cell lines and primary human samples of acute myeloid leukemia (AML). In an effort to identify additional downstream targets of Meis1, we generated FDC-P1 cells overexpressing Meis1 in the presence or absence of HoxA9. Microarray analysis was performed on RNA isolated from these cells. A combination of bioinformatics and statistical analyses were used to look for genes with differential regulation in the presence or absence of Meis1 and HoxA9. These data were used to generate a genetic signature characteristic of Meis1 expression and shed light onto other pathways that may involve Meis1 and HoxA9.

Indexing (details)


Subject
Genetics;
Oncology
Classification
0369: Genetics
0992: Oncology
Identifier / keyword
Health and environmental sciences, Biological sciences, Breast cancer, Cancer genes, Caveolin, Insertional mutagenesis, Leukemia, Meis1, Sleeping beauty
Title
Insertional Mutagenesis as a Tool for Identifying and Characterizing Novel Candidate Cancer Genes
Author
Roth, Jacquelyn Jinan
Number of pages
258
Publication year
2011
Degree date
2011
School code
0272
Source
DAI-B 72/11, Dissertation Abstracts International
Place of publication
Ann Arbor
Country of publication
United States
ISBN
9781124802091
Advisor
Buchberg, Arthur M.
Committee member
Calabretta, Bruno; Jaynes, James; Zhang, Jianke
University/institution
Thomas Jefferson University
Department
Genetics
University location
United States -- Pennsylvania
Degree
Ph.D.
Source type
Dissertations & Theses
Language
English
Document type
Dissertation/Thesis
Dissertation/thesis number
3466634
ProQuest document ID
885421493
Copyright
Database copyright ProQuest LLC; ProQuest does not claim copyright in the individual underlying works.
Document URL
http://search.proquest.com/docview/885421493
Access the complete full text

You can get the full text of this document if it is part of your institution's ProQuest subscription.

Try one of the following:

  • Connect to ProQuest through your library network and search for the document from there.
  • Request the document from your library.
  • Go to the ProQuest login page and enter a ProQuest or My Research username / password.